Prenetics Announces Formation of Scientific Advisory Board to Support New Business Strategy in Precision Oncology

March 2, 2023

https://www.globenewswire.com/news-release/2023/03/02/2619108/0/en/Prenetics-Announces-Formation-of-Scientific-Advisory-Board-to-Support-New-Business-Strategy-in-Precision-Oncology.html

LONDON and HONG KONG, March 02, 2023 (GLOBE NEWSWIRE) — Prenetics Global Limited (NASDAQ:PRE), a leader in genomic and diagnostic testing, is proud to announce the formation of a new Prenetics Scientific Advisory Board (the ‘SAB’) to provide strategic input based on their scientific knowledge and clinical expertise to help guide the further development of Prenetics’ diagnostic cancer genomics platform.

Read more at globenewswire.com

Related news for (PRE)

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money.